Novaliq and Jiangsu Hengrui Medicine Announce a Strategic Collaboration in Ophthalmology for the EyeSol(R)-based, Investigational Products NOV03 and CyclASol(R) in China HealthCare November 9, 2019 Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276),…
